Two Sigma Securities, LLC Akebia Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

$716 Million
Q4 2024

A detailed history of Two Sigma Securities, LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 40,826 shares of AKBA stock, worth $78,385. This represents 0.01% of its overall portfolio holdings.

Number of Shares

40,826

Previous 13,309 206.75%

Holding current value

$78,385

Previous $17,000 341.18%

% of portfolio

0.01%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.26 - $2.13 $34,671 - $58,611	27,517 Added 206.75%	40,826 $75,000
Q3 2024 Nov 14, 2024	BUY	$0.94 - $1.55 $12,510 - $20,628	13,309 New	13,309 $17,000
Q1 2024 May 15, 2024	BUY	$1.27 - $2.24 $25,656 - $45,252	20,202 Added 170.18%	32,073 $58,000
Q4 2023 Feb 14, 2024	SELL	$0.8 - $1.28 $4,025 - $6,440	-5,032 Reduced 29.77%	11,871 $14,000
Q3 2023 Nov 14, 2023	SELL	$0.87 - $1.84 $7,292 - $15,422	-8,382 Reduced 33.15%	16,903 $19,000
Q2 2023 Aug 14, 2023	SELL	$0.51 - $1.43 $57,503 - $161,235	-112,752 Reduced 81.68%	25,285 $23,000
Q1 2023 May 15, 2023	BUY	$0.56 - $1.15 $30,390 - $62,409	54,269 Added 64.78%	138,037 $77,000
Q4 2022 Feb 14, 2023	BUY	$0.25 - $0.58 $14,408 - $33,427	57,634 Added 220.53%	83,768 $48,000
Q3 2022 Nov 14, 2022	SELL	$0.3 - $0.46 $2,839 - $4,353	-9,465 Reduced 26.59%	26,134 $8,000
Q2 2022 Aug 15, 2022	BUY	$0.32 - $0.67 $1,097 - $2,298	3,430 Added 10.66%	35,599 $13,000
Q1 2022 May 16, 2022	SELL	$0.72 - $2.93 $534 - $2,174	-742 Reduced 2.25%	32,169 $23,000
Q4 2021 Feb 14, 2022	BUY	$2.26 - $3.34 $26,102 - $38,577	11,550 Added 54.07%	32,911 $74,000
Q3 2021 Nov 15, 2021	BUY	$2.35 - $3.88 $50,198 - $82,880	21,361 New	21,361 $62,000
Q2 2021 Aug 16, 2021	SELL	$2.83 - $4.2 $39,750 - $58,993	-14,046 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.92 - $5.06 $41,014 - $71,072	14,046 New	14,046 $48,000
Q1 2020 May 15, 2020	SELL	$4.1 - $10.24 $125,845 - $314,306	-30,694 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.16 - $6.73 $96,993 - $206,570	30,694 New	30,694 $194,000
Q1 2019 May 15, 2019	SELL	$5.41 - $8.73 $55,641 - $89,788	-10,285 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$5.39 - $9.15 $55,436 - $94,107	10,285 New	10,285 $57,000

Others Institutions Holding AKBA

# of Institutions

127

Shares Held

62.8M

Call Options Held

50.6K

Put Options Held

203K

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $353M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account

Two Sigma Securities, LLC Akebia Therapeutics, Inc. Transaction History